✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Cosmo Pharmaceuticals NV

Common Name
Cosmo Pharmaceuticals
Country
Ireland
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
332
Ticker
COPN
Exchange
SIX Swiss Exchange
Description
Cosmo Pharmaceuticals N.V. is a pharmaceutical company specializing in the development and commercialization of innovative products for gastroenterology, dermatology, and health technology worldwide. ...

Cosmo Pharmaceuticals's Revenues Data

Explore Cosmo Pharmaceuticals's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.

Metric2025202420232022-2019
Total Revenue(USD)
122,473,205a
277,623,595a
102,690,760b
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Cosmo Pharmaceuticals’s Revenues Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Cosmo Pharmaceuticals's Annual Report 2025
b. Cosmo Pharmaceuticals's Annual Report 2024